You are here

  • Home
  • Archive
  • Volume 31, Issue 1
  • ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemothera…

Article metrics

Article menu
Download PDFPDF
Clinical trial
ICON 9—an international phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy

 

Online download statistics by month:

Online download statistics by month: October 2020 to November 2024

AbstractFullPdf
Oct 20205521910
Nov 20203721913
Dec 20201981610
Jan 20219562611
Feb 202147863
Mar 20212911610
Apr 202123952
May 20218222
Jun 2021215
Jul 2021221
Aug 2021545
Sep 20211358
Oct 202114432
Nov 202115300
Dec 202121154
Jan 202221578
Feb 202214013
Mar 202230237
Apr 202221512
May 202213611
Jun 202213753
Jul 202214655
Aug 202216713
Sep 202213645
Oct 202216153
Nov 202213224
Dec 202210624
Jan 20239201
Feb 202313320
Mar 202310614
Apr 202310531
May 202311844
Jun 20239111
Jul 202310536
Aug 20239635
Sep 202310611
Oct 202310411
Nov 20239433
Dec 202332545
Jan 2024209129
Feb 202418242
Mar 202415111
Apr 202411969
May 202417536
Jun 202412656
Jul 202415765
Aug 202417645
Sep 202419335
Oct 202411823
Nov 20248621
Total8858240218